ITGA3 and prostate carcinoma: Biotinylated anti-EpCAM, anti-ITGA3 or anti-CD63 antibodies were applied for capturing EVs from cell culture supernatants of the prostate cancer cell lines LNCaP, DU145 and PC3 and one of the control cell line HEK293.